CLL is characterized by the clonal expansion of CD5+ B cells in blood, bone marrow, and secondary lymphoid tissues, and appears to be driven by altered cellular signaling and typical genetic aberrations [4]. This evidence concerns the gene CD5 and B-cell chronic lymphocytic leukemia.